by Öner Tulum, William Lazonick, and Ken Jacobson Despite vaccines’ significant public-health benefits, sales of all vaccines accounted for less than four percent of $872 billion in prescription-drug…
Tag: Oner Tulum
#1. Is there enough production capacity available for the vaccine supply to meet urgent demand in 2021?
by Öner Tulum, William Lazonick, and Ken Jacobson As COVID-19 vaccines receive regulatory approval, the world has a powerful weapon to fight the coronavirus. But at what pace…
4 Burning Questions on the Global Vaccine Rollout
Warnings of “corruption and incompetence coming together,” as economists William Lazonick and Öner Tulum study the race to end the pandemic.
4 Ways to Eradicate the Corporate Disease That is Worsening the Covid-19 Pandemic
“It’s time for business executives, employees, and taxpayers to come together to help get us out of the pandemic and create conditions for a sustainable and equitable future Here are the key ways to respond to the coronavirus crisis and…